Laboratory Diagnostic Solutions

Advisory for Established Clinical Laboratories Expanding Test Menus, Platforms, and LIS

Laboratory Diagnostic Solutions provides vendor-neutral advisory support for laboratories that are already operational and need to make defensible decisions before adding platforms, assays, or laboratory information systems (LIS). We align technical capability with workflow, staffing, validation burden, integration constraints, and reimbursement reality.

We deliver decision frameworks, documentation templates, and implementation-ready plans. Your laboratory executes testing, validation runs, and final approvals.

What We Do

We help laboratories reduce downstream regret. Most errors in lab expansion are not “technical mistakes”—they’re misalignments between what the lab wants to offer and what the lab can reliably run, support, validate, interface, and bill.

Engagements typically focus on one or more of the following:

How We Approach Laboratory Decisions

In laboratories, every “good” decision has second-order effects. A platform can be analytically excellent and still fail operationally if the validation burden is underestimated, staffing is mismatched, LIS limitations block automation, or payer behavior makes the test menu financially unstable.

We evaluate decisions as a system, including:

The goal is to prevent “technically correct, operationally painful” outcomes.This approach helps laboratories avoid misalignment between technology, operations, and regulatory expectations.

Diagnostic Modalities We Support

We support operational laboratories adding capability or tightening performance across multiple diagnostic environments.

Molecular Diagnostics

PCR and nucleic-acid workflows: assay strategy, specimen handling, throughput planning, validation structure, and payer-driven risk factors.

Clinical Chemistry

Chemistry analyzer and menu planning for routine and specialty testing—selection decisions that account for volume, staffing, QC burden, and scalability.

Advanced Testing Platforms

LC-MS and other high-complexity environments where staffing, validation complexity, maintenance realities, and LIS integration decisions carry outsized downstream risk.

Laboratory Information System (LIS) Guidance

LIS decisions shape workflow, interfaces, reporting, billing, and scalability. Many laboratories commit to systems before understanding integration limitations that are expensive to unwind.

We provide LIS selection guidance based on modality, test menu, staffing, interface needs, and reporting/billing requirements—not vendor claims. We do not sell LIS software. Our role is to clarify tradeoffs, constraints, and long-term implications before you commit.

Validation Planning & Documentation Support

We build validation plans and documentation frameworks aligned with CLIA/COLA expectations—study design, acceptance criteria, control strategy, and readiness checklists—so your team can execute efficiently and document defensibly.

SOP & Compliance Documentation Development

We organize SOP architecture and compliance documentation to match your test complexity, menu, and operational model. Deliverables can include SOP templates, customization guidance, and full compliance-manual structure that is practical to maintain—not just “binder-filling.”

Vendor Neutrality & Assay Sourcing

Laboratory Diagnostic Solutions is vendor-neutral by design. We are not compensated by any single platform to recommend their system.

When requested, we can support assay sourcing through a limited set of manufacturers and distributors (including Biomiga, Laboratory Advanced Solutions, and Abbott). Any sourcing support is optional and separate from the advisory engagement. Recommendations are driven by laboratory fit, validation burden, and operational requirements—not exclusivity.

Next Step

If you are expanding a test menu, evaluating platforms, selecting an LIS, or tightening validation and compliance documentation—and want a technically grounded, vendor-neutral perspective—schedule a call.

Most engagements begin with a structured review to define scope, risks, and the fastest defensible path forward.